您的当前位置:首页 > 行业数据 > 部分GLP-1/GIP/GCGR靶点药物疗效及安全性对比
图片属性
图片格式:PNG 图片大小:369KB 图片尺寸:2346*863
同报告图片
 / 4
部分GLP-1/GIP/GCGR靶点药物疗效及安全性对比_第1页
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
部分GLP-1/GIP/GCGR靶点药物疗效及安全性对比_第2页
部分GLP-1/GIP/GCGR靶点药物疗效及安全性对比_第3页
部分GLP-1/GIP/GCGR靶点药物疗效及安全性对比_第4页
部分GLP-1/GIP/GCGR靶点药物疗效及安全性对比_第5页
所属报告: 【国金证券】医药行业研究:GLP-1专题,产品迭代驱动市场扩容,关注靶点、剂型及联合疗法研发进展-251117(38页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠